Share this
Turning Point Therapeutics to Sell to Bristol Myers Squibb for $4.1 Billion
June 3, 2022
Alvotech Agrees to Merge With SPAC Oaktree Acquisition Corp. II
Transaction to accelerate company’s mission of bringing cost-effective biosimilars to patients in all major markets around the globe • December 9, 2021
Baylis Medical Agrees to Sell to Boston Scientific for $1.75 Billion
October 21, 2021
Warby Parker – Direct Listing
First public benefit corporation to trade on public markets through direct listing • October 13, 2021
ZOLL Medical Agrees to Acquire Itamar Medical for $538 Million
September 21, 2021
Lyell Immunopharma – $425 Million IPO
Third largest biotech IPO in history • July 20, 2021
Olive Closes $225 Million Financing, Acquires Verata Health
December 14, 2020
Opthea – $128 Million IPO
Largest IPO by a development-stage Australian life sciences company • November 3, 2020
ArcherDX Agrees to Combine With Invitae in $1.4 Billion Deal
June 24, 2020
Orca Bio Raises $192 Million Series D to Transform Allogeneic Cell Therapy
June 23, 2020
Cooley Advises on Follow-On Offerings for Reata + argenx
Transactions total more than $1 billion • December 5, 2019